Phase II Trial of Daily Dose of Oral Vaccine Against Atherosclerosis
Phase of Trial: Phase III
Latest Information Update: 27 Aug 2018
At a glance
- Drugs Atherosclerosis vaccine (Primary)
- Indications Atherosclerosis
- Focus Pharmacodynamics; Registrational
- Sponsors Immunitor
- 16 Aug 2018 Planned End Date changed from 18 May 2018 to 18 Dec 2018.
- 16 Aug 2018 Planned primary completion date changed from 18 Feb 2018 to 18 Dec 2018.
- 27 Mar 2017 Status changed from active, no longer recruiting to recruiting.